Presentation Information

[3P-315]Engineering of Cross-Reactive Single-Domain Antibodies Targeting SARS-CoV2 Variants

○Hidekazu Masaki1,2, Ryo Yonehara1, Kanako Nakao1, Naoto Nemoto1,2 (1. Epsilon Molecular Engineering, 2. Saitama Univ.)

Password required to view


Comment

To browse or post comments, you must log in.Log in